CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 4 incoming connections
- ScaleMarket cap is $2.5B, above the global median of $1.18B
- PositionGross margin is 63.6%, higher than 95% of its Scientific & Technical Instruments peers (median 40.4%)
- Interpretations9 currently firing — 9
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.63%
Annual Rate
CNY 0.66Paid annual
Payout Ratio
66.0%Moderate
Last Ex-Dividend
Jun 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
16.76BCNY2.50B · vs all stocks (USD)
Trailing P/E
91.79xvs Scientific & Technical Instruments peers
Revenue (TTM)
680.94MCNY101.64M · vs all stocks (USD)
Profit Margin
23.13%vs Scientific & Technical Instruments peers
Beta
1.14xvs all stocks
52-Week Change
190.97%vs all stocks
Market Capitalization
16.76BCNY2.50B · vs all stocks (USD)
Enterprise Value
11.05BCNY1.65B · vs all stocks (USD)
Trailing P/E
91.79xvs Scientific & Technical Instruments peers
Forward P/E
55.97xvs Scientific & Technical Instruments peers
Price to Sales (TTM)
21.51xvs Scientific & Technical Instruments peers
Price to Book (MRQ)
9.22xvs Scientific & Technical Instruments peers
Enterprise to Revenue
16.23xvs Scientific & Technical Instruments peers
Enterprise to EBITDA
66.73xvs Scientific & Technical Instruments peers
Gross Margin
63.60%vs Scientific & Technical Instruments peers
Profit Margin
23.13%vs Scientific & Technical Instruments peers
Operating Margin
27.65%vs Scientific & Technical Instruments peers
Return on Assets (TTM)
5.57%vs Scientific & Technical Instruments peers
Return on Equity (TTM)
10.10%vs Scientific & Technical Instruments peers
Revenue (TTM)
680.94MCNY101.64M · vs all stocks (USD)
Revenue per Share (TTM)
4.32CNYUpdated Sep 22, 2026Quarterly Revenue Growth
33.20%vs Scientific & Technical Instruments peers
Gross Profit (TTM)
428.50MCNY63.96M · vs all stocks (USD)
EBITDA (TTM)
172.97MCNY25.82M · vs all stocks (USD)
Net Income (TTM)
157.51MCNY23.51M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
47.70%vs Scientific & Technical Instruments peers
Operating Cash Flow (TTM)
144.28MCNY21.54M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
44.70MCNY6.67M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.6600CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.63%vs all stocks
Payout Ratio
66.00%vs Scientific & Technical Instruments peers
Revenue
602.02MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
231.90MCNYFY2025 · Dec 31, 2025Gross Profit
370.12MCNYFY2025 · Dec 31, 2025Operating Income
118.40MCNY17.67M · vs all stocks (USD)
Pre-tax Income
148.02MCNYFY2025 · Dec 31, 2025Income Tax Expense
5.43MCNYFY2025 · Dec 31, 2025Net Income
142.59MCNYFY2025 · Dec 31, 2025EBIT
149.72MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
178.47MCNYFY2025 · Dec 31, 2025Research & Development
145.02MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
54.43MCNYFY2025 · Dec 31, 2025Other Operating Expenses
4.47MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
29.46MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.70MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
142.59MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
128.11MCNYFY2025 · Dec 31, 2025Free Cash Flow
99.45MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.25BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
142.59MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.03MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-30.02MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
14.51MCNYFY2025 · Dec 31, 2025Capital Expenditures
-28.66MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-28.66MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-81.19MCNYFY2025 · Dec 31, 2025Other Financing Charges
-6.66MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-87.85MCNYFY2025 · Dec 31, 2025Shares Outstanding
159.60MSharesUpdated Sep 22, 2026Float Shares
49.48MSharesUpdated Sep 22, 2026% Held by Insiders
70.79%vs all stocks
% Held by Institutions
5.87%vs all stocks
Total Cash (MRQ)
1.19BCNY177.93M · vs all stocks (USD)
Total Cash per Share (MRQ)
7.47CNYUpdated Sep 22, 2026Total Debt (MRQ)
33.77MCNY5.04M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0213xvs Scientific & Technical Instruments peers
Current Ratio (MRQ)
11.72xvs Scientific & Technical Instruments peers
Book Value per Share (MRQ)
9.96CNYUpdated Sep 22, 2026Total Assets
1.76BCNY262.89M · vs all stocks (USD)
Total Current Assets
1.64BCNYFY2025 · Dec 31, 2025Total Liabilities
156.76MCNYFY2025 · Dec 31, 2025Total Non-current Assets
121.46MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
27.69MCNYFY2025 · Dec 31, 2025Total Current Liabilities
129.07MCNYFY2025 · Dec 31, 2025Cash
1.25BCNYFY2025 · Dec 31, 2025Cash Equivalents
564.57KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.29BCNYFY2025 · Dec 31, 2025Accounts Receivable
95.21MCNYFY2025 · Dec 31, 2025Inventory
214.94MCNYFY2025 · Dec 31, 2025Accounts Payable
55.92MCNYFY2025 · Dec 31, 2025Short-term Debt
12.56MCNYFY2025 · Dec 31, 2025Other Current Liabilities
110.20KCNYFY2025 · Dec 31, 2025Long-term Debt
23.94MCNYFY2025 · Dec 31, 2025Common Stock (Book)
159.60MCNYFY2025 · Dec 31, 2025Retained Earnings
270.93MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.60BCNY239.49M · vs all stocks (USD)
52-Week Low
34.35CNYUpdated Sep 22, 202652-Week High
106.98CNYUpdated Sep 22, 202652-Week Change
190.97%vs all stocks
Beta
1.14xvs all stocks
50-Day MA
60.24CNYUpdated Sep 22, 2026200-Day MA
53.85CNYUpdated Sep 22, 2026Avg 10-Day Volume
4.62MSharesUpdated Sep 22, 2026Avg 30-Day Volume
4.12MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
1.00CNYUpdated Sep 22, 20269 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
Is this company growing?
Growth With Volume Backing
Revenue and net income have compounded over six years, and volume has leaned up with it.
Reads
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 63.6%, higher than 95% of its Scientific & Technical Instruments peers (median 40.4%)Significant
Gross margin: 0.64Industry median: 0.40Industry P95: 0.63Peers compared: 31.00
Current ratio is 11.72×, higher than 95% of its Scientific & Technical Instruments peers (median 2.9×)Significant
Current ratio: 11.72Industry median: 2.90Industry P95: 6.35Peers compared: 31.00
Supply Chain
Midstream position: 6 outgoing, 4 incoming connectionsNotable
Outgoing: 6.00Incoming: 4.00
High connectivity hub: 10 industry connectionsNotable
Total Connections: 10.00
Scale
Market cap is $2.5B, above the global median of $1.18BNotable
Market cap (USD): 2,501,656,084.078Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Winner Medical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Elite Advanced Laser Corp.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Cecep Solar Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Ingevity Corporation
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Renew Energy Global Plc
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Autel Intelligent Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Bloomage Biotechnology Corp.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
NeoGenomics Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Cecep Environmental Protection Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
BGI Genomics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
All-Ring Tech Co., Ltd.
6 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsGrowth With Volume BackingLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Anhui XDLK Microsystems Co., Ltd.
7 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMinimal Tax and Interest DragCash-Flow Ratios ElevatedMulti-Year Revenue, Profit, And Income GrowthLiquidity Ratios ElevatedLow-Leverage Liquidity ConfigurationMulti-Year Revenue And Profit Growth
King Slide Works Co., Ltd.
6 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedLow-Leverage Liquidity ConfigurationMulti-Year Revenue And Profit Growth